Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 25
- Locations
- 1
- Primary Endpoint
- Immune analysis
Study Overview
Brief Summary
This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.
Detailed Description
This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people: a randomized, double-blind, placebo-controlled, and parallel clinical investigation.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 50 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Subjects are easy to feel fatigued
- •Subjects have poor sleep quality
Exclusion Criteria
- •Pregnant women or preparing for pregnancy.
- •Lactating women.
- •Women gave birth 6 months before the study.
- •Poor kindy and livers funcitons
- •Severe cardiovascular or other chronic diseases
- •Alcohol abuser
- •Using immune-associated supplements
Arms & Interventions
Placebo
Placeo group
Intervention: Placebo (Dietary Supplement)
Treatment
Experimental group
Intervention: Antrodia cinnamomea mycelia (Dietary Supplement)
Outcomes
Primary Outcomes
Immune analysis
Time Frame: Baseline up to 4 weeks
Changes in T cell markers of 29 participants will be analyzed between baseline and week 4.
Antibody analysis
Time Frame: Baseline up to 4 weeks
Changes in IgA levels of 29 participants will be analyzed between baseline and week 4.
Cytokine analysis
Time Frame: Baseline up to 4 weeks
Changes in IL-1beta levels of 29 participants will be analyzed between baseline and week 4.
Secondary Outcomes
No secondary outcomes reported